| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Edmund Harrigan | Director | 2026-09-30 | 206 | $121.35 | $25.00kBuy |
| Paul J. Clancy | Director | 2026-09-30 | 203 | $121.35 | $24.63kBuy |
| David H. Gardner | CStrat;EVP | 2026-09-22 | 920 | $126.93 | $116.78kSell |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 4,551 | $61.18 | $278.43kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 13,985 | $120.49 | $1.69MSell |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 6,477 | $64.25 | $416.15kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 9,233 | $71.93 | $664.13kBuy |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 9,233 | $120.50 | $1.11MSell |
| Pablo J. Cagnoni | Pres;Head | 2026-09-15 | 2,957 | $61.76 | $182.62kBuy |
| Ramitpal K. Basi | EVP | 2026-08-25 | 504 | $129.72 | $65.38kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Julian Baker | 9.79% | 19,851,744 | $2.29B | Insider |
| Baker Brothers Life Sciences LP | 6.14% | 12,445,783 | $1.43B | Insider |
| Baker Brothers Life Sciences Capital GP LLC | 6.13% | 12,430,783 | $1.43B | Insider |
| Baker Biotech Capital GP LLC | 2.42% | 4,911,003 | $566.24M | Insider |
| 667 LP | 1.01% | 2,038,937 | $235.09M | Insider |
| Roy A. Whitfield | 0.33% | 666,082 | $76.80M | Insider |
| 14159 Capital GP LLC | 0.32% | 651,582 | $75.13M | Insider |
| Baker Bros Advisors LP | 0.19% | 381,420 | $43.98M | Insider |
| 14159 LP | 0.18% | 370,839 | $42.76M | Insider |
| Herve Hoppenot | 0.17% | 352,703 | $40.67M | Insider |